Tate & Lyle Ventures

Tate & Lyle Ventures

$40,000,000 Venture capital (Series C)
FinSMEs

Evolve BioSystems Raises $40M in Series C Financing

Funding Science
$8,000,000 Venture capital (Series A)
foodingredientsfirst.com/ , Richmond BizSense , sec

Tate & Lyle Leads US$8 Million Investment in Chickpea Innovator Nutriati

$20,000,000 Venture capital (Series B)
PE HUB

Evolve Biosystems snags $20 mln Series B

Messaging